The Office of Biomedical Advanced Research and Development Authority (BARDA), within the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS) seeks to establish partnerships to build the next iteration of the BARDA Accelerator Network (BAN 2.0) using BARDA’s Other Transaction Authority to foster the health security innovation ecosystem with commercialization and wrap-around support and to enable rapid development, evaluation, validation, and commercialization of medical countermeasures. With BAN 2.0, BARDA aims to further enhance the global health security innovation ecosystem, optimize startup acceleration and wrap-around services, and ultimately develop the Accelerator Network as a scalable infrastructure for commercialization including active product development support, and validation capabilities during regular operations as well as rapid response during public health emergencies. 

BARDA envisions that BAN 2.0 will support BARDA’s mission by addressing the following objectives/tasks:

• Support health security innovators, startups, and existing BARDA partners already receiving BARDA funding (“BARDA funded partners”) by providing wraparound accelerator services including entrepreneurship education and access to technical and business/commercialization expertise and resources.
• Provide BARDA with capabilities to source, review, fund, and accelerate startups and perform product development, evaluation, and validation of MCMs based on BARDA’s strategic priorities.
• Build a rapid emergency response infrastructure to fund and accelerate product development and validation of MCMs that can be developed and deployed as quickly as possible in the event of a public health emergency.

BARDA intends to enter into other transaction agreements with five or more Accelerator Hub organizations with each Accelerator Hub providing resources and support focused on one of the following Technology Areas:

• Therapeutics/Vaccines
• Diagnostics/Medical Devices
• Digital Health
• Enabling Technologies (e.g., Biomanufacturing/Drug Development/Clinical Support)
• Special Populations (e.g., Pediatrics, low resource settings)

Submissions are due at 12:00PM ET on the due dates listed below for each technology area. BARDA may adjust the closing date for submissions under any of the following technology areas through amendment of this notice.

• Diagnostics/Medical Devices on September 15, 2023, with the intent to make an award within 90-120 days of the proposal due date.
• Therapeutics/Vaccines on October 2, 2023, with the intent to make an award within 90-120 days of the proposal due date.
• Enabling Technologies on October 2, 2023, with the intent to make an award within 90-120 days of the proposal due date.
• Digital Health on January 12, 2024, with the intent to make an award within 90-120 days of the proposal due date.
• Special Populations (e.g., Pediatrics, Immunocompromised, Low Resource Settings) on January 12, 2024, with the intent to make an award within 90-120 days of the proposal due date.

Additional information is available in the attached solicitation documents. Additionally, please visit https://drive.hhs.gov/.